Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Doctors need to be better prepared to assess and treat obesity in patients.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

The study found that family history, personal history of adolescent acne, no pregnancies, hirsutism, office work, stress, and low intake of fruits/vegetables and fish are risk factors for adult female acne.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Men with testicular cancer were less likely to experience baldness and severe acne.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Human hair contains more glycosaminoglycans in children than adults, and these compounds decrease with age, possibly affecting hair thickness.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.